companydata.dkcompanydata.dk

Nordic Liposomes ApS: Financial statements 2025

CVR: 43161725

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Nordic Liposomes ApS (CVR 43161725) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 546,069 and a net result of DKK 336,862 compared with DKK 66,871 the year before. That is an increase of 445% compared with the year before. Equity in the 2025 report amounted to DKK 443,608. The solvency ratio was 49.4%.

Gross Profit
DKK 546,069
Profit/Loss
DKK 336,862
Equity
DKK 443,608
Total Assets
DKK 898,003
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-546K337K444K0
2024-100K67K107K0
2023-104K68K40K0

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Nordic Liposomes ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Nordic Liposomes ApS: The 2024 annual report is outApr 16, 2025

Nordic Liposomes ApS has published its annual report for 2024. Gross profit came to DKK 100,194, and the net result was DKK 66,871.

About Nordic Liposomes ApS

Nordic Liposomes ApS is a Danish company of the type Anpartsselskab based in Søndersø, founded in 2022. The company is registered under the industry Andre fremstillingsaktiviteter i.a.n.. The company was previously named Nordicliposomes ApS. The management consists of Morten Thvilum and Trine Albers Huusfeldt. The company is owned by CIRRUS HOLDING ApS and Huusfeldt ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 546,069 and a net result of DKK 336,862 compared with DKK 66,871 the year before. Equity in the 2025 report amounted to DKK 443,608.

Source: annual report 2025, Danish Business Authority

Other financial years